A detailed history of Creative Planning transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 10,944 shares of PTCT stock, worth $501,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,944
Previous 10,128 8.06%
Holding current value
$501,672
Previous $309,000 31.39%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$30.39 - $37.66 $24,798 - $30,730
816 Added 8.06%
10,944 $406,000
Q2 2024

Aug 15, 2024

BUY
$24.69 - $40.12 $39,973 - $64,954
1,619 Added 19.03%
10,128 $309,000
Q1 2024

May 10, 2024

BUY
$24.15 - $31.95 $205,492 - $271,862
8,509 New
8,509 $247,000
Q2 2022

Aug 15, 2022

SELL
$25.6 - $45.23 $188,620 - $333,254
-7,368 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$35.36 - $41.86 $954 - $1,130
-27 Reduced 0.37%
7,368 $293,000
Q3 2021

Nov 10, 2021

BUY
$37.01 - $44.74 $273,688 - $330,852
7,395 New
7,395 $275,000
Q2 2021

Aug 04, 2021

SELL
$37.95 - $49.37 $193,734 - $252,033
-5,105 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$46.8 - $68.92 $4,680 - $6,892
-100 Reduced 1.92%
5,105 $242,000
Q4 2020

Jan 29, 2021

SELL
$47.96 - $67.64 $353,369 - $498,371
-7,368 Reduced 58.6%
5,205 $318,000
Q2 2020

Jul 23, 2020

BUY
$42.56 - $54.98 $42,560 - $54,980
1,000 Added 8.64%
12,573 $638,000
Q1 2020

May 05, 2020

BUY
$32.37 - $59.36 $238,502 - $437,364
7,368 Added 175.22%
11,573 $516,000
Q4 2019

Jan 30, 2020

BUY
$32.22 - $50.07 $135,485 - $210,544
4,205 New
4,205 $202,000
Q1 2018

Apr 18, 2018

SELL
$17.46 - $32.59 $244,806 - $456,944
-14,021 Closed
0 $0
Q4 2017

Jan 17, 2018

BUY
$15.14 - $20.89 $212,277 - $292,898
14,021
14,021 $234,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.28B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.